...
首页> 外文期刊>The pharmaceutical journal >MHRA issues alert but Clexane will not be recalled
【24h】

MHRA issues alert but Clexane will not be recalled

机译:MHRA发出警报,但不会召回Clexane

获取原文
获取原文并翻译 | 示例
           

摘要

Batches of Clexane(enoxaparin sodium;Sanofi-Aventis)containing low-levels of a contami nant called over-sulphated chondroitin sulphate (OSCS)have been distrib uted in the UK,the Medicines and Healthcare products Regulatory Agency announced last week.OSCS has been suspected by the US Pood and Drug Administration to be the contaminant contained in other heparin products,used in the US,Australia,China and some European countries,which have been associated with a rise in serious adverse events,including deaths.
机译:上周,英国药品和保健产品监管局宣布,已分发了一批含有低含量的硫酸盐软骨素硫酸盐(OSCS)污染物的克列斯汀(依诺肝素钠;赛诺菲-安万特)。在美国,澳大利亚,中国和一些欧洲国家使用的肝素产品中,被美国Pood and Drug Administration怀疑是其他肝素产品中所含的污染物,这些污染物与严重的不良事件(包括死亡)相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号